Niacin (Vitamin B3) Toxicity: Blood Sugar and Gout
At the high doses once used to treat cholesterol — roughly 1,000 to 2,000 mg a day, far above the few milligrams in food or a multivitamin — niacin (vitamin B3) can nudge two lab numbers in the wrong direction: it can raise fasting blood sugar, worsening glucose control in people with or at risk of diabetes, and it can raise serum uric acid, which in susceptible people can tip them into an attack of gout. These are real, dose-dependent effects of niacin therapy — documented in large trials like AIM-HIGH and HPS2-THRIVE — not a danger of the ordinary niacin in a balanced diet. This page explains how high-dose niacin pushes glucose and uric acid up, why most people will never encounter this, who is genuinely at risk, and what to watch for.
Table of Contents
- What It Feels Like
- The Mechanism: How High-Dose Niacin Raises Glucose and Urate
- Honest Context: Many Things Raise Blood Sugar and Uric Acid
- Clues That Niacin Is the Culprit
- Where the Dose Comes From
- Getting Checked
- What To Do
- When to Seek Care / Red Flags
- Key Research Papers
- Connections
- Featured Videos
What It Feels Like
The first thing to understand is that rising blood sugar and rising uric acid from niacin usually announce themselves not as a feeling but as a number on a lab report. A modest rise in fasting glucose causes no symptoms at all; you would not notice it without a blood test. The same is true of a rising uric acid level — until, in some people, it crosses a threshold and crystallizes in a joint. So for most people on high-dose niacin, the only “symptom” is a lab value their clinician points out.
When symptoms do appear, they take two distinct forms:
- Higher blood sugar. If glucose climbs far enough — usually only in someone with diabetes or prediabetes — the familiar signs of high blood sugar can emerge: increased thirst, more frequent urination, fatigue, and blurred vision. In someone with well-controlled diabetes, the more common experience is simply that their home glucose readings or their hemoglobin A1c have crept up since starting niacin.
- A gout flare. This is unmistakable. Gout typically strikes a single joint — classically the base of the big toe — with sudden, severe pain that often wakes a person in the early morning hours. The joint becomes red, hot, swollen, and so exquisitely tender that even the weight of a bedsheet is unbearable. An attack builds over hours, peaks within a day, and, untreated, settles over a week or two. Niacin does not cause gout from nothing; it raises uric acid, which can trigger a flare in someone already prone to it.
It is worth separating these two effects from the most famous reaction to high-dose niacin — the niacin flush, a harmless wave of warmth and redness across the face and chest. Flushing is immediate and obvious; the glucose and urate effects are slow, silent, and detectable only by testing or, in the case of gout, by an eventual attack. They are also unrelated to the rarer, more serious problem of niacin liver damage, which is covered separately.
The Mechanism: How High-Dose Niacin Raises Glucose and Urate
These two effects come from two different actions of niacin, but both only matter at the gram-a-day pharmacologic doses used to treat lipids — hundreds of times the amount in food. At nutritional doses, niacin is simply a precursor of the coenzyme NAD and has none of these effects.
Why blood sugar rises
The leading explanation involves fatty acids and the body's sensitivity to insulin. Niacin's whole purpose as a lipid drug is to suppress the release of free fatty acids from fat tissue, which is why it lowers triglycerides. But the body adapts. After the dose wears off, there is a rebound: free fatty acids surge back higher than before. Chronically elevated free fatty acids make muscle and liver less responsive to insulin — a state called insulin resistance. To keep glucose in range, the pancreas has to work harder; in someone whose pancreas is already strained (prediabetes or diabetes), it cannot fully keep up, and fasting glucose drifts upward. The effect is real but generally modest — on the order of a few points of fasting glucose and a fraction of a percentage point on A1c — and it is largely reversible when niacin is stopped.
An analogy. Think of insulin as a key that unlocks cells to let glucose in. High-dose niacin does not break the key — it gums up the lock with excess fatty acids, so the same key turns less smoothly. A person with plenty of spare keys (a healthy pancreas) barely notices. A person already short on keys (diabetes) finds the door sticking, and glucose backs up in the blood.
Why uric acid rises
Uric acid is the waste product of purine breakdown, and the kidneys are responsible for clearing most of it. They do this through transporter proteins in the kidney tubule — notably URAT1 — that decide how much urate is reabsorbed back into the blood versus excreted in urine. The catch is that this transporter handles several substances that compete for the same exit. Nicotinic acid is metabolized to compounds (such as nicotinuric acid) that are themselves excreted by the kidney and compete with urate for that pathway. When niacin floods the system at high doses, urate loses the competition: less is excreted, more stays in the blood, and the serum uric acid level rises. In someone whose uric acid already sits near the saturation point, that extra nudge can be enough to form the needle-sharp crystals that ignite a gout attack.
An analogy. Picture the kidney's urate exit as a single turnstile that several passengers share. Normally uric acid passes through steadily. Flood the turnstile with niacin's by-products and they crowd in line, so urate has to wait — and the backed-up urate accumulates in the blood until, in a vulnerable joint, it precipitates out as crystals.
Honest Context: Many Things Raise Blood Sugar and Uric Acid
This is the most important point on the page, and it cuts in two directions. First, high-dose niacin is an uncommon cause of either problem, because so few people take therapeutic niacin today — the large outcome trials (below) cooled enthusiasm for it. Second, both a high glucose and a high uric acid have many far more common explanations, so neither finding should be blamed on niacin without good reason.
Common drivers of a high fasting glucose that have nothing to do with niacin include type 2 diabetes and prediabetes themselves, excess weight and inactivity, a recent high-carbohydrate meal or stress, illness or infection, and a long list of medications — corticosteroids (steroids) are a classic example, as are thiazide diuretics and some antipsychotics. If your glucose is up, the question is rarely “is it the niacin?” unless you are actually taking high-dose niacin.
Common drivers of a high uric acid include genetics (the single biggest factor), being male, kidney disease that limits urate clearance, a diet rich in red meat, organ meats, shellfish, beer and other alcohol, and sugary (fructose-sweetened) drinks, obesity, dehydration, and a different set of medications — thiazide and loop diuretics are the prime offenders, along with low-dose aspirin and ciclosporin. Niacin belongs on this list, but well down it.
So if you develop gout or a rising glucose and you are not taking gram-level niacin, the cause is almost certainly something else. And even if you are, a clinician will weigh niacin against these other contributors rather than assume it is to blame.
Clues That Niacin Is the Culprit
A few features make high-dose niacin a more plausible explanation, and they are worth knowing if you are on it or considering it:
- Dose and form. The effects are tied to therapeutic doses — roughly 1–2 grams a day of nicotinic acid (prescription or high-dose over-the-counter), not the 14–18 mg in food or the small amount in a multivitamin. If your niacin intake is nutritional, it is essentially never the cause.
- Timing. A glucose or uric acid that rises in the weeks to months after starting or increasing high-dose niacin — and improves after stopping it — points toward niacin. A change that predates the niacin does not.
- An existing predisposition. Niacin's glucose effect shows up mainly in people with diabetes or prediabetes; its gout effect shows up mainly in people who already have hyperuricemia or a history of gout. In someone with neither, the same dose of niacin usually moves both numbers only slightly and harmlessly.
- Which niacin. The blood-sugar and uric-acid effects belong to nicotinic acid (the flushing, lipid-active form). Plain nicotinamide (niacinamide) and the marketing-driven “no-flush” inositol hexanicotinate do not have the lipid effects — and inositol hexanicotinate is largely inactive for cholesterol — so they are not the typical sources of this problem. See the Vitamin B3 overview for the differences between these forms.
None of these clues is proof. They simply tell a clinician whether niacin deserves a place on the list of suspects, alongside the more common causes above.
Where the Dose Comes From
To raise glucose or uric acid, niacin has to be taken in pharmacologic amounts, and there are only a few realistic ways that happens:
- Prescription niacin for cholesterol. The classic source. For decades, extended-release nicotinic acid (e.g. Niaspan) was prescribed at 1–2 grams a day to raise HDL and lower triglycerides — an approach now used far less after the niacin-and-cholesterol trials failed to show it prevented heart attacks when added to a statin (see Key Research Papers).
- High-dose over-the-counter niacin. Nicotinic acid is sold without a prescription in 500 mg and larger tablets, and is sometimes self-prescribed for cholesterol or as part of unproven “detox” regimens. Taken at multi-gram doses, it carries the same metabolic effects — and the same need for monitoring — as the prescription product, but without medical oversight.
- Megadose “orthomolecular” use. Some people take grams of niacin daily based on alternative-health claims. At those doses the glucose and uric-acid effects (and the risk of liver injury) become relevant.
What does not cause this: eating niacin-rich foods such as meat, fish, poultry, peanuts, and fortified grains, or taking a standard multivitamin. The dietary amounts are orders of magnitude below the therapeutic range, and the body simply uses what it needs and excretes the small excess.
Getting Checked
Both effects are detected the same way they are caused — by a simple blood test — and anyone on high-dose niacin should have these monitored as a matter of routine.
For blood sugar, the relevant tests are a fasting glucose and the hemoglobin A1c, which reflects the average glucose over the prior two to three months. A fasting insulin level can add context about insulin resistance, and people with diabetes on niacin may be asked to watch their home glucose meter or a continuous glucose monitor more closely after starting it. The practical rule is to check glucose before beginning high-dose niacin and again after a few weeks to months, so any drift is caught early.
For uric acid, a serum uric acid test measures the level directly. One important caveat: the uric acid number does not diagnose a gout attack by itself. Many people have a high uric acid and never get gout, and — confusingly — the level can even dip to normal during an acute flare. A definitive diagnosis of gout rests on the clinical picture and, when needed, on finding urate crystals in fluid drawn from the inflamed joint. So uric acid is the number to monitor, but a gout flare is diagnosed by an examining clinician, not by the lab value alone.
What To Do
Because these are dose-dependent effects of a medication, the response is straightforward and is best made with the prescriber, not on your own — especially since niacin is usually being taken for a reason.
- Reassess whether the niacin is needed at all. This is the central question. Given that high-dose niacin added to a statin did not reduce cardiovascular events in the large AIM-HIGH and HPS2-THRIVE trials — while raising the rate of new diabetes and other adverse effects — many people on niacin for lipids can simply stop it after a conversation with their clinician. If the niacin is not buying a clear benefit, the glucose and uric-acid downsides are not worth carrying.
- If niacin continues, monitor and adjust. When there is still a reason to use it, the dose can be lowered, glucose and uric acid tracked on a schedule, and diabetes or gout medication adjusted to compensate. A modest, well-monitored rise in glucose is not automatically a reason to stop a drug that is genuinely helping — but it must be a deliberate, watched decision.
- Treat a gout flare on its own merits. An acute attack is managed the usual way — anti-inflammatory medication (an NSAID, colchicine, or a short course of steroids) under medical guidance — regardless of whether niacin contributed. Stopping the niacin lowers uric acid going forward but does not relieve a flare already underway.
- Address the bigger levers. For both glucose and uric acid, the everyday factors usually matter more than the niacin: weight, activity, alcohol, sugary drinks, and other medications such as thiazide diuretics. Tart cherry, hydration, and dietary changes are commonly used adjuncts for urate — see tart cherry for uric acid and gout — though they complement, rather than replace, medical management.
The overarching principle: niacin is the easiest variable to remove, so when it is contributing and not clearly helping, removing it is usually the simplest and best fix.
When to Seek Care / Red Flags
These effects are rarely emergencies, but a few situations warrant prompt medical attention — and anyone on high-dose niacin should keep their prescriber in the loop rather than self-managing:
- A first or severe gout-like attack — sudden, intense pain, redness, heat, and swelling in a single joint (often the big toe). It should be evaluated, both to confirm the diagnosis (it can be confused with a joint infection, which is a true emergency) and to treat the inflammation properly.
- A red, hot, swollen joint with fever — this combination can signal an infected joint (septic arthritis) rather than gout and needs urgent assessment, as it can damage the joint quickly.
- Symptoms of markedly high blood sugar in a person with diabetes — excessive thirst, frequent urination, and unexplained fatigue or blurred vision after starting niacin — should prompt a glucose check and a call to the prescriber; the niacin or the diabetes regimen may need adjusting.
- Any high-dose niacin without monitoring. If you are taking gram-level niacin (prescription or over-the-counter) and have not had your glucose, uric acid, and liver enzymes checked, arrange it — this is the single most useful step, because both of these effects, and the more serious risk of liver injury, are silent until tested for.
For nearly everyone else — people getting niacin from food or a multivitamin — none of this applies. Dietary niacin does not raise blood sugar or uric acid, and there is nothing to watch for.
Key Research Papers
- AIM-HIGH Investigators; Boden WE, Probstfield JL, Anderson T, et al. (2011). Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. New England Journal of Medicine;365(24):2255-2267. — DOI: 10.1056/NEJMoa1107579
- HPS2-THRIVE Collaborative Group; Landray MJ, Haynes R, Hopewell JC, et al. (2014). Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients. New England Journal of Medicine;371(3):203-212. — DOI: 10.1056/NEJMoa1300955
- Goldie C, Taylor AJ, Nguyen P, et al. (2016). Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials. Heart;102(3):198-203. — DOI: 10.1136/heartjnl-2015-308055
- Elam MB, Hunninghake DB, Davis KB, et al. (2000). Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease: The ADMIT Study. JAMA;284(10):1263-1270. — DOI: 10.1001/jama.284.10.1263
- Grundy SM, Vega GL, McGovern ME, et al. (2002). Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes: The ADVENT Study. Archives of Internal Medicine;162(14):1568-1576. — DOI: 10.1001/archinte.162.14.1568
- Kamanna VS, Kashyap ML (2008). Mechanism of Action of Niacin. American Journal of Cardiology;101(8A):20B-26B. — DOI: 10.1016/j.amjcard.2008.02.029
- Coronary Drug Project Research Group (1975). Clofibrate and Niacin in Coronary Heart Disease. JAMA;231(4):360-381. — DOI: 10.1001/jama.1975.03240160024021
- Canner PL, Berge KG, Wenger NK, et al. (1986). Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Journal of the American College of Cardiology;8(6):1245-1255. — DOI: 10.1016/S0735-1097(86)80293-5
- Guyton JR, Goldberg AC, Kreisberg RA, et al. (1998). Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. American Journal of Cardiology;82(6):737-743. — DOI: 10.1016/S0002-9149(98)00955-2
- Enomoto A, Kimura H, Chairoungdua A, et al. (2002). Molecular identification of a renal urate–anion exchanger that regulates blood urate levels. Nature;417(6887):447-452. — DOI: 10.1038/nature742
- Choi HK, Atkinson K, Karlson EW, et al. (2004). Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men. New England Journal of Medicine;350(11):1093-1103. — DOI: 10.1056/NEJMoa035700
- Richette P, Bardin T (2010). Gout. The Lancet;375(9711):318-328. — DOI: 10.1016/S0140-6736(09)60883-7
PubMed Topic Searches
- PubMed — Niacin, glucose, and insulin resistance
- PubMed — Niacin and new-onset diabetes / glycemic control
- PubMed — Niacin and hyperuricemia
- PubMed — Nicotinic acid and renal urate excretion
- PubMed — Niacin therapy, adverse effects, and gout
Connections
- Niacin Toxicity Hub
- Niacin Toxicity and Skin Flushing
- Niacin Toxicity and Liver Damage
- Vitamin B3 (Niacin) Overview
- Niacin Deficiency Hub
- Niacin and Cholesterol
- Gout
- Diabetes
- Uric Acid Test
- Hemoglobin A1c
- Fasting Insulin
- Continuous Glucose Monitor
- Tart Cherry for Uric Acid and Gout
- Chanca Piedra, Uric Acid and Gout
- Coffee and Type 2 Diabetes